Key result
Customized lipid-lowering therapy shows no link to altered carotid plaque composition over one year.
Why the study?
The relationship between circulating lipoproteins and high-risk carotid plaque features, such as lipid-rich necrotic core and intraplaque hemorrhage, is unclear.
Do changes in circulating lipoproteins correlate with changes in carotid plaque composition (fat fraction and R2) in patients with carotid plaques?
Observational (n=52)
Do changes in circulating lipoproteins correlate with changes in carotid plaque composition (fat fraction and R2) in patients with carotid plaques?
Changes in circulating lipoproteins following customized lipid-lowering therapy do not correlate with changes in carotid plaque composition (fat fraction and R2) over 1 year, suggesting a complex relationship.
Answers are grounded in this paper and cite their sources.
Lipoprotein changes were unassociated with carotid plaque composition over 1 year; leaves open determinants of plaque fat fraction in observational data.
BACKGROUND: Lipid-rich necrotic core (LRNC) and intraplaque hemorrhage (IPH) are morphological features of high-risk atherosclerotic plaques. However, their relationship to circulating lipoproteins is unclear. PURPOSE: To study associations between changes in lipoproteins vs. changes in LRNC (represented by fat fraction [FF]) and IPH (represented by R2*). STUDY TYPE: Prospective. SUBJECTS: Fifty-two patients with carotid plaques, 33 males (63.5%), mean age 72 (±5). FIELD STRENGTH/SEQUENCE: weighted sequences to guide manual segmentation. ASSESSMENT: Carotid MRI and serum lipid levels were assessed at baseline and at 1-year follow-up. For patients, lipid-lowering therapy was customized to reduce low-density lipoprotein (LDL) levels below 1.8 mmol/L. Segmentation was performed with one set of regions of interest for the plaque and one for the vessel wall at the location of the plaque. Thereby MRI data for FF, R2*, and volumes in plaque- and vessel-wall segmentations could be obtained from baseline and follow-up, as well as changes over the study year. STATISTICAL TESTS: Pearson correlation coefficient for correlations. Paired samples t-test for changes over time. Significance at P < 0.05, 95% confidence interval. Plaque composition remained unchanged, FF +8.5% (P = 0.366) and R2* +3.5% (P = 0.304). Compared to plaque segmentations, R2* was significantly lower in the vessel-wall segmentations both at baseline (-9.3%) and at follow-up (-9.1%). DATA CONCLUSION: The absence of correlations between changes in lipoproteins and changes in plaque composition indicates more complex relationships between these parameters than previously anticipated. The significant differences in both R2* and volume dynamics comparing plaque segmentations and vessel-wall segmentations suggest differences in their pathobiology of atherosclerosis. LEVEL OF EVIDENCE: 1 TECHNICAL EFFICACY: Stage 4.
No takes yet. Share an insight, caveat, or question.
Good et al. (2021) conducted an observational in Carotid plaques (n=52). Customized lipid-lowering therapy (target LDL < 1.8 mmol/L) was evaluated on Associations between changes in lipoproteins and changes in plaque fat fraction (FF) and R2. Over 1 year of customized lipid-lowering therapy, carotid plaque composition remained unchanged, with no correlation to lipoprotein changes.
Synapse has enriched 10 related papers. Consider them for comparative context: